KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme Group (CME) Free Cash Flow: 2009-2024

Historic Free Cash Flow for Cme Group (CME) over the last 16 years, with Dec 2024 value amounting to $3.6 billion.

  • Cme Group's Free Cash Flow fell 2.41% to $949.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 billion, marking a year-over-year increase of 12.56%. This contributed to the annual value of $3.6 billion for FY2024, which is 6.49% up from last year.
  • According to the latest figures from FY2024, Cme Group's Free Cash Flow is $3.6 billion, which was up 6.49% from $3.4 billion recorded in FY2023.
  • In the past 5 years, Cme Group's Free Cash Flow ranged from a high of $3.6 billion in FY2024 and a low of $2.3 billion during FY2021.
  • For the 3-year period, Cme Group's Free Cash Flow averaged around $3.3 billion, with its median value being $3.4 billion (2023).
  • Its Free Cash Flow has fluctuated over the past 5 years, first dropped by 9.65% in 2021, then soared by 30.38% in 2022.
  • Over the past 5 years, Cme Group's Free Cash Flow (Yearly) stood at $2.5 billion in 2020, then declined by 9.65% to $2.3 billion in 2021, then surged by 30.38% to $3.0 billion in 2022, then increased by 13.86% to $3.4 billion in 2023, then grew by 6.49% to $3.6 billion in 2024.